The formal 2016 ACR/EULAR criteria require biopsy and Schirmer testing — neither is practical in primary care. This tool is calibrated for the PCP's actual question: does this patient need anti-SSA antibodies or a rheumatology referral? Anti-SSA (Ro) is the single most useful first test.
Evidence Base
Adapted from the 2016 ACR/EULAR classification criteria for primary Sjögren's syndrome, with objective tests (biopsy, Schirmer) weighted heavily because of their high specificity. Anti-SSA is the most clinically accessible high-weight item and should be ordered whenever Sjögren's is suspected.
~96%
Anti-SSA sensitivity
~74%
Specificity for pSS
F:M ≈ 9:1
Sex ratio
1
Sicca Symptoms
Chronic dryness of eyes or mouth is the cardinal presenting complaint. Symptoms must be present for ≥3 months and not fully explained by medications.
Chronic dry eyes >3 months
Daily, persistent — patient may describe gritty, sandy, or burning sensation; sensitivity to light
+1
Chronic dry mouth >3 months
Persistent xerostomia — reduced or absent saliva, not medication-related
+1
Needs to drink water to swallow food
A specific and clinically useful question — reflects significant salivary gland dysfunction
+1
Recurrent or accelerated dental caries
New cavities in a previously healthy dentition, especially at cervical margins — a consequence of hyposalivation
+1

Medication review is essential. Anticholinergics, antihistamines, antidepressants (TCAs, SSRIs), antihypertensives, and diuretics all cause dry eyes and mouth. Sicca from medications does not score toward Sjögren's — but Sjögren's can coexist with polypharmacy.

2
Associated Features
Extraglandular features that raise suspicion for systemic autoimmune disease beyond sicca alone.
Parotid gland enlargement
Bilateral, painless, recurrent swelling over the preauricular area — highly specific for Sjögren's when present
+2
Arthralgias or non-erosive arthritis
Symmetric joint pain, usually small joints — present in ~50% of Sjögren's patients
+1
Significant fatigue
One of the most burdensome symptoms — present in ~70% of patients; not explained by other causes
+1
Raynaud's phenomenon
Present in ~13–30% of Sjögren's patients — triphasic color change (white → blue → red) with cold or stress
+1
Peripheral neuropathy (unexplained)
Small fiber neuropathy or sensory neuropathy — an underrecognized extraglandular manifestation
+1
⚠ Parotid Enlargement — Lymphoma Surveillance
Patients with primary Sjögren's have a ~5–16× increased risk of B-cell lymphoma, most commonly MALT lymphoma of the parotid gland. Parotid swelling that is unilateral, firm, or rapidly enlarging warrants imaging and urgent rheumatology referral. Any known Sjögren's patient with new parotid enlargement should be evaluated promptly.
3
Objective Tests (if available)
These carry the highest diagnostic weight in the formal criteria. Include any results already available — leave unchecked if not yet obtained.
Anti-SSA (Ro) antibody positive
~96% sensitivity for pSS · The single most useful first-line test · Order whenever Sjögren's is considered
+3
Positive minor salivary gland biopsy
Focus score ≥1 per 4 mm² — gold standard; typically performed by rheumatology or oral medicine
+3
Schirmer test ≤5 mm in 5 minutes
Objective measure of tear production — typically performed by ophthalmology
+1

Anti-SSB (La) alone is insufficient — it should always be ordered alongside anti-SSA and has lower sensitivity. A positive ANA with speckled pattern at ≥1:320 also increases suspicion. Normal ANA does not exclude Sjögren's — up to 25% of pSS patients are ANA-negative.

i
Conditions That Mimic Sjögren's
Sicca symptoms are non-specific. These are the most common causes to consider first.
DiagnosisDistinguishing Features
Medication-induced sicca Anticholinergics, antihistamines, TCAs, SSRIs, diuretics — review medication list first
Age-related dryness Common in older adults, no systemic features, normal inflammatory markers, ANA/SSA negative
IgG4-related disease Parotid/lacrimal enlargement, elevated IgG4, responds well to steroids
Sarcoidosis Hilar adenopathy, elevated ACE, non-caseating granulomas on biopsy
Sicca in SLE Anti-dsDNA, low complement, multi-system involvement — Sjögren's and SLE overlap is common
Fibromyalgia Diffuse pain, normal labs including SSA/SSB, no glandular abnormality
Clinical Pearls
💊
Check the Medication List First
Dry mouth and dry eyes from polypharmacy are extremely common in older adults. Always review the full medication list before attributing sicca to Sjögren's.
🦷
Dental History Is Diagnostic
Ask: "Have you been getting more cavities lately, even with good dental hygiene?" Accelerated cervical caries in a previously cavity-free patient is a strong clue for Sjögren's.
👁️
Dry Eye ≠ Sjögren's
Most dry eye is evaporative (meibomian gland disease), not autoimmune. Ophthalmology referral is helpful when symptoms are severe or Schirmer testing is needed.
🤝
Overlap Is Common
Secondary Sjögren's occurs in RA, SLE, and systemic sclerosis. A positive SSA in a patient already diagnosed with another CTD doesn't change management of the primary disease.

Frequently Asked Questions

Common questions clinicians and patients ask after using this tool — and after receiving these results.

What are the most common symptoms of Sjögren's syndrome?
Dry eyes and dry mouth are the hallmark symptoms of Sjögren's syndrome, but the disease is far more than a dryness condition. Patients often describe gritty or burning eyes, needing water to swallow food, accelerated dental decay, and difficulty speaking for long periods. Fatigue — often severe and disproportionate — is one of the most disabling features. Joint pain, brain fog, and peripheral neuropathy are common. Parotid gland swelling (puffiness in front of the ears or under the jaw) on both sides is one of the most specific clinical features. Symptoms often predate diagnosis by 5–10 years.
What is the difference between primary and secondary Sjögren's?
Primary Sjögren's syndrome occurs on its own, without another underlying autoimmune disease. Secondary Sjögren's refers to sicca features (dry eyes, dry mouth) occurring in the context of another autoimmune condition — most commonly rheumatoid arthritis (30%), SLE (20%), and systemic sclerosis. Both forms share similar symptoms and antibody profiles, but secondary Sjögren's management is guided by the primary disease. Anti-SSA (Ro) positivity is common in both forms. This calculator assesses features of primary Sjögren's.
What do anti-SSA and anti-SSB antibodies mean?
Anti-SSA (Ro) and anti-SSB (La) are the signature antibodies of Sjögren's syndrome. Anti-SSA (Ro) is present in approximately 50–75% of primary Sjögren's patients and is the more sensitive of the two. Anti-SSB (La) is less common (~25–40%) but more specific. Both antibodies can also be found in SLE. An important clinical consequence: anti-SSA positivity in a pregnant woman significantly raises the risk of neonatal lupus and congenital heart block in the fetus, requiring fetal cardiac monitoring. A negative anti-SSA does not exclude Sjögren's — approximately 25–40% of patients are seronegative.
Is Sjögren's syndrome dangerous?
For most patients, Sjögren's causes significant morbidity through dryness, fatigue, and neuropathy — but is not life-threatening. However, Sjögren's carries an approximately 15–20× increased risk of non-Hodgkin's B-cell lymphoma compared to the general population, particularly mucosa-associated lymphoid tissue (MALT) lymphoma. Risk factors for lymphoma include parotid gland enlargement, palpable purpura, cryoglobulinemia, low complement, and high-grade lymphocytic focus score on lip biopsy. Any new parotid swelling or unexplained lymphadenopathy in a Sjögren's patient warrants lymphoma surveillance.
Does Sjögren's cause fatigue?
Yes — fatigue is one of the most prevalent and debilitating symptoms of Sjögren's syndrome, reported by 70–80% of patients and often rated as their most impactful symptom. The fatigue in Sjögren's is not fully explained by sicca symptoms alone and appears to have central and inflammatory components. It is not well-controlled by hydroxychloroquine in most patients, and there is no proven disease-modifying therapy specifically for Sjögren's fatigue. Evaluation should exclude contributing factors including anemia, thyroid disease, sleep apnea, and depression, all of which are more common in Sjögren's patients.
Can men get Sjögren's syndrome?
Yes, though Sjögren's syndrome is predominantly a disease of middle-aged women with a female:male ratio of approximately 9:1. Men account for about 10% of Sjögren's patients. Men with Sjögren's tend to present later, are more likely to be seronegative (anti-SSA negative), and have a higher rate of extraglandular manifestations including peripheral neuropathy and renal tubular acidosis. The diagnosis is often delayed in men because dry eyes and dry mouth are less frequently attributed to autoimmune disease. Men with unexplained peripheral neuropathy and sicca features should be screened for Sjögren's.
References
  1. Shiboski CH, et al. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome. Ann Rheum Dis. 2017;76(1):9–16.
  2. Ramos-Casals M, et al. Primary Sjögren syndrome. Nat Rev Dis Primers. 2020;6(1):52.
  3. Vitali C, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61(6):554–558.
  4. Brito-Zerón P, et al. Sjögren syndrome. Nat Rev Dis Primers. 2016;2:16047.
  5. Nocturne G, Mariette X. B cells in the pathogenesis of primary Sjögren syndrome. Nat Rev Rheumatol. 2015;11(4):224–234.